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Epigallocatechin Gallate’s Protective Effect against
MMP7 in Recessive Dystrophic Epidermolysis Bullosa
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Sylvie Se´guier1, Yves de Prost2, Christine Bodemer2, Gaston Godeau1 and Karim Senni1
The analysis of phenotype–genotype correlations of patients suffering from recessive dystrophic epidermolysis
bullosa (RDEB) evidenced intrafamilial and interfamilial phenotype variability occurring for the same mutation
of COL7A1; this underscores the role of other genetics environmental factors in the expressivity of the disease.
In this work, we checked whether matrilysin 1 (matrix metalloproteinase (MMP)7) could take part in the
epidermal detachment in RDEB. Furthermore, we investigated epigallocatechin 3 gallate (EGCG) to determine
whether it could inhibit matrilysin activities on collagen type VII and fibrillin 1 known to be associated with the
dermo-epidermal junction. In this work, matrilysin 1 was detected in affected and unaffected skins of the three
RDEB patients; furthermore, MMP7 was shown to degrade ex vivo on healthy normal skin collagen VII and
fibrillin 1. Thus, we suspect that MMP7 could take an active part in the epidermal detachment occurring during
RDEB. We evidenced that EGCG in in vitro as well as in ex vivo experiments was a good inhibitor of MMP7 and
developed a good protection of collagen type VII and fibrillin 1 susceptible of being degraded by MMP7. We
therefore propose that EGCG could be used beneficially in patients suffering from RDEB.
Journal of Investigative Dermatology (2007) 127, 821–828. doi:10.1038/sj.jid.5700645; published online 30 November 2006
INTRODUCTION
In the most severe form of recessive dystrophic epidermolysis
bullosa (RDEB) ‘‘Hallopeau-Siemens’’ type, collagen type VII
is mostly absent but in some cases rare anchoring fibrils
composed of this collagen type at the dermo-epidermal
junction are still present (Bruckner-Tuderman et al., 1989). A
number of COL7A1 mutations have been reported in RDEB
patients and the analysis of phenotype–genotype correlations
has shown evidence of interfamilial and intrafamilial
phenotypic variabilities occurring for the same mutations
(Hovnanian et al., 1997). These results underscore the role of
other genetics or environmental factors in expression of the
disease.
In a previous work conducted in three RDEB-affected
sibling brothers with the same mutation in COL7A1, we
evidenced that the amounts of matrix metalloproteinase
(MMP)1, MMP2, MMP3, and MMP9 increased particularly in
the skin of the more clinically affected patient (Bodemer
et al., 2003). We also noted with this patient higher amounts
of MMP1 as well as lower amounts of TIMP1 in his affected
and unaffected skins compared with the other two affected
patients and healthy control donors, suggesting that tissue
destruction in the disease process results from an imbalance
of MMP with tissue inhibitor of metalloproteinases (Bodemer
et al., 2003). In this work, our aim was to determine whether
matrilysin 1 (MMP7), could be involved in the epidermal
detachment in RDEB patients as this MMP was shown to be
present in the culture media of affected and unaffected skins
maintained in organ culture. Furthermore, with cryostat
section of two healthy human control skins, we investigated
whether MMP7 was able ex vivo to hydrolyze some
extracellular matrix (ECM) components associated with the
dermo-epidermal junction that is, collagen VII and fibrillin 1.
We investigated as well whether there was a potential
inhibitory effect on MMP7 in ex vivo experiments using
human control skin cryostat sections of epigallocatechin
gallate (EGCG) because this polyphenolic compound derived
from green tea has been demonstrated in in vitro experiments
to be able to inhibit matrilysin activity in a non-competitive
manner with Ki value of 0.47–1.65mmol (Oneda et al., 2003).
RESULTS
Skin biopsies
Immunostaining of matrilysin 1 (MMP7). The MMP7 immuno-
peroxydase labeling of the skins of the three RDEB patients
in affected and non-affected skins (patients M, T, F, Figure S1:
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a, b, c, unaffected skins; d, e, f: affected skins) revealed an
intense staining of the epidermis in the affected as well as in
the unaffected skins of the three RDEB patients compared
with control skin for which a discreet labeling was observed
at the epidermis level (Figure S1g).
Colocalization of MMP7 and CD68
Double labeled of MMP7 and CD68 for macrophages have
been performed on affected and unaffected skin of RDEB
patients. As shown both markers are present within the same
cells in the dermis of affected skin patient (Figure 1), leading
us to suppose that macrophages are involved in the
production of MMP7 in RDEB skin patient.
Staining of elastic fibers
After (þ ) catechin-fuchsin staining, three types of fibers
could be distinguished: oxytalan fibers perpendicular to the
dermo-epidermal junction, elaunin fibers parallel to the
dermo-epidermal junction, and mature elastic fibers in the
dermis in the two control donors (see Figure S2a control no
1). With RDEB patients, skin elastic network was consider-
ably disorganized particularly oxytalan fibers were dispersed
and rarefied in affected and unaffected skins of the three
RDEB patients as illustrated for patient F (see Figure S2: b,
unaffected skins; c, affected skin).
Qualitative analysis of MMP7 secreted from skin explants after
72 hours of organ culture. Western blotting analysis
Qualitative analysis: SDS-PAGE and Western blotting of
proteins secreted in the conditioned media of skin explants
from the three affected and non-affected skins of patients with
RDEB were analyzed. In non-affected skin patient, MMP7 in
non-reducing conditions was detected as bands with
approximate molecular weight of 97 kDa (Figure 2a, line
L1). In reducing conditions (Figure 2a, line L2), this band
appears as two bands: one at about 66 kDa and the other at
25–30 kDa.
In affected skin of the same patient, in non-reducing
conditions, MMP7 is detected as two bands one at 97 kDa
and the other at 66 kDa (Figure 2a, line L4). In reducing
conditions, three bands are evidenced at 25–30 kDa, at
66 kDa, and a faint band at 97 kDa (Figure 2a, line L3). With
controls, no bands for MMP7 were observed (not shown).
To show the specificity of the antibody used for MMP7,
rhMMP7 detection was performed after Western blotting and
was detected with an apparent molecular weight of about
20 kDa (see Figure 2b).
Quantitative analysis: The amounts of MMP7 were
increased in the culture conditioned media for unaffected
or affected skins in patients F, M, and T. The increase being
particularly clear for patient M. For this patient, the amount
of MMP7 expressed from his unaffected skin is about
37,973 a.u., whereas the amount expressed from the affected
skin is about 42,136 a.u. as illustrated in Figure 2c.
In vitro assay for inhibition of MMP7 activity using EGCG as
possible inhibitor
Matrilysin activities appeared on casein zymograms as bands
with an apparent molecular weight of 20 kDa, caseinolytic
activities being proportional to the amounts of MMP7
electrophorized (125, 250, 500 ng of MMP7) (not shown).
When rhMMP7 (500 ng) is submitted to an incubation with
EGCG, whatever the amount of EGCG the caseinolytic
activity of MMP7 is totally abolished (see Figure 3a).
When EGCG is added at 30 mg/ml or 60mg/ml to the
incubation buffer media after electrophoresis, the intensity of
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Figure 1. Colocalization of CD 68 and MMP7 in affected skin of RDEB
patients. Positive cells for CD68 appeared in (a) red and positive cells for
MMP7, in (b) green . Both markers were shown to be present simultaneously
within same cells in the RDEB skin. Bar¼20 mm.
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Figure 2. MMP7 detection and quantification in culture media. (a) MMP7
detection by Western blotting after 72 hours of culture. MMP7 was detected in
the culture media of affected and unaffected skins of RDEB patient M under
reducing and non-reducing conditions. In the unaffected skin (line L1, L2), in
non-reducing condition (L1), a spot of 90 kDa can be detected, whereas under
reducing conditions (L2) two bands appear at 66 and 25–30 kDa. In the
affected skin (line L3, L4) under non-reducing condition, two spots at 90 and
66 kDa are observed, whereas under reducing condition three bands at 25, 66
and 97 kDa can be detected. (b) rhMMP7 detection by Western blotting.
RhMMP7 (1 mg) was detected after electrophoresis to show the specificity of
the antibody used. (c) Quantification of MMP7 in conditioned media of
patient M after Western blotting.
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the caseinolytic activity is proportional to the amount of
EGCG added (see Figure 3b). The inhibition of the case-
inolytic activity after image analysis was estimated at 43%
with 30 mg/ml of EGCG and 76% with 60 mg/ml of EGCG (see
Figure 3c).
When EGCG is co-polymerized with casein gel an
inhibition of MMP7 activity of 26 and 64% is observed
respectively for EGCG at 60 mg/ml or 120mg/ml (see Figure
3d).
Enzymatic digestion and immunodetection of collagen type VII
and fibrillin 1
When skin sections were incubated with buffer alone,
collagen VII (see Figure 5a) was observed as net continuous
and linear labeling underlying the dermo-epidermal junction;
fibrillin 1 was observed as thin branches of candelabrum
perpendicular to the dermo-epidermal basement membrane
and also associated with elastic fibers of the dermis (see
Figure 4a). When tissue sections were incubated with
increasing quantities of MMP7, the skin matrilysin degrada-
tion was clearly visible for the higher amount of rhMMP7
(200 ng) concerning collagen VII which after immunodetec-
tion was noted thin and punctiform (see Figure 5b).
Concerning fibrillin 1 it appeared considerably rarefied and
disorganized (see Figure 4b) when compared with tissue
section incubated with buffer alone (see Figure 4a).
Skin sections were incubated with EGCG (43 ng), then
indirect immunodetection of collagen VII and fibrillin 1 was
performed as described in Materials and Methods, and we
verified that EGCG alone did not affect the quality and
intensity of the immunotection of collagens VII and fibrillin 1
(not shown). On the other hand, when rhMMP7 (200 ng) and
EGCG (43 ng) were preincubated during 1 hour at 371C and
were deposited onto a set of control skin tissue sections for a
period of 48 hours at 371C after indirect immunodetection of
collagen VII (see Figure 5c) and fibrillin 1 (see Figure 4c), no
discernable breakdown was observed for the two ECM
components mentioned above, the intensity of the immuno-
staining being identical to that obtained after incubation with
the buffer alone.
When control skin tissue sections were preincubated with
the buffer containing 43 ng of EGCG during 1 hour at 371C
then submitted during 48 hours at 371C to the action of
200 ng of rhMMP7, the quality and intensity of the immuno-
detection of collagen VII and fibrillin 1 were comparable
to those evidenced without MMP7 (not shown).
In the first set of experiments, MMP7 and EGCG were first
mixed and incubated for 1 hour then deposited onto the tissue
sections, whereas in the second set of experiments the tissue
sections were first incubated with EGCG for 1 hour before the
addition of MMP7 (not shown). These two sets of experiments
gave the same results, illustrating the inhibition effect of
EGCG on the actions of human MMP7 toward collagen VII
and fibrillin 1.
DISCUSSION
In the present work, we hypothesized that matrilysin
(MMP7) could take part in the epidermis detachment which
occurs at skin level in patients suffering from RDEB. There-
fore, we conducted immunomorphological analysis on
affected and non-affected skins from three RDEB patients
belonging to the same family and presenting the same
mutations in COL7A1.
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Figure 3. Effect of EGCG on caseinolytic activity of MMP7. (a) Incubation of
EGCG with rhMMP7 before electrophoretic migration. L1: rhMMP7 (500 ng)
was incubated with EGCG (60 mg/ml); L2: rhMMP7 (500 ng) was incubated
with EGCG (30mg/ml); L3: rhMMP7 alone. Preincubation of MMP7 with
EGCG induced an inhibition of caseinolytic activity. (b) Caseinolytic activity
of MMP7 after incubation with EGCG added in the incubation buffer. L1:
rhMMP7 (500 ng) was incubated with EGCG (60 mg/ml); L2: rhMMP7 (500 ng)
was incubated with EGCG (30 mg/ml); L3: rhMMP7 without EGCG. EGCG in
the incubation buffer induce an inhibition of MMP7 caseinolytic activity.
(c) Quantification of MMP7 activity on casein zymography after addition of
EGCG in the incubation buffer. EGCG at 30 or 60mg/ml induce a dose-
dependant inhibition of MMP7 caseinolytic activity. (d) Quantification of
MMP7 activity after zymography on casein gel co-polymerized with EGCG.
EGCG at 60 or 120mg/ml induce a dose-dependant inhibition of the
caseinolytic activity.
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MMP7 belongs to a family of zinc-dependent enzymes
able to degrade a wide range of matrix molecules (Woessner,
1994; Massova et al., 1998). They play a major role in
connective tissue remodeling in embryonic development and
in wound repair (Woessner, 1991). MMP7 has been shown to
degrade in vitro the ECM proteins (Imai et al., 1995), gelatins
(Type I, II, IV, V) (Woessner, 1994), collagen type IV (Murphy
et al., 1991), laminin (Miyazaki et al., 1990), entactin/
nidogen (Mayer et al., 1993), and elastin (Murphy et al.,
1991). The proteolytic activities of MMP7 have been defined
by experiments using activated recombinant enzymes and
purified substrates. Using monoclonal antibodies directed
against human matrilysin 1 (MMP7), we evidenced that
MMP7 was expressed in the outer root sheath of hair
follicules and sweat glands in the two human healthy control
skins, this result being in accordance with those reported by
Karelina et al. (1994). In the affected and non-affected skins
of the three RDEB patients, MMP7 was immunodetected at
the level of the keratinocytes and several cells were also
shown positive for MMP7 in the dermis not far from the zone
which corresponds to the detachment between the epidermis
and the dermis. In the dermis of affected patients, some cells
were positive both for MMP7 and CD68, a marker of
macrophages.
This expression of matrilysin by human mononuclear
phagocytes was also reported by Busiek et al. (1995) who in
the process of examining various cutaneous and lung
inflammatory disorders for matrilysin expression by immuno-
histochemistry and in situ hybridization found that mono-
cytes within blood vessels and extravasated tissue-associated
macrophages exhibited matrilysin production. We observed
after staining of skin elastic network by (þ ) catechin fuchsin
that mature elastic fibers were considerably diminished and
pre-elastic fibers rarefied and disorganized in the affected
skin as well as in the unaffected skin of the three RDEB
patients when compared with control skins. This observation
concerning pre-elastic fibers and RDEB skins is in accordance
with the results reported by McGrath et al. (1994) who
observed in areas of dermal–epidermal separation a number
of thin fragmented wisp-like structures labeled for fibrillin.
Because matrilysin was shown to develop elastolytic activity
(Murphy et al., 1991) in vitro, we endeavored to verify using
human skin cryostat sections from skin of control healthy
Ep
Der
Ep
Ep
Der
Der
20 m 20 m 20 m
a b c
Figure 4. Immunodetection of fibrillin 1. Indirect immunodetection of fibrillin 1 was performed on skin from (a) healthy control donor without enzymatic
treatment, on skin from healthy control donor (b) with enzymatic digestion with rhMMP7, and on skin from healthy control donor (c) after incubation with
EGCGþ rhMMP7. (Ep: epidermis; Der: dermis). Bar¼mm. (a) Immunodetection of fibrillin 1 on skin from healthy control donor (anti-fibrillin dilution: 1/50).
Bar¼20 mm. (b) Immunodetection of fibrillin 1 (dilution 1/50) on skin from healthy control donor after incubation at 371C in a moist chamber with 200 ng of
rhMMP7. The immunodetction of fibrillin 1 is clearly altered with rarefaction of fibrillin fibers in the superficial dermis. Bar¼20 mm. (c) Immunodetection of
fibrillin 1 (dilution 1/50) on skin from healthy control donor treated as follows: rhMMP7 (200 ng) and EGCG 43ng were co-incubated during 1 hour at 371C in a
moist chamber then deposited on to the tissue section during 48 hours at 371C. Positive fibrillar structures were comparable to those observed in panel a.
Bar¼20 mm.
Der
Ep
Ep
Ep
Der
Der
20 m 20 m 20 m
a b c
Figure 5. Immunodetection of Collagen type VII. Indirect immunodetection
of collagen type VII was performed on skin from healthy control donor
without enzymatic treatment (7a), on skin from healthy control donor with
enzymatic digestion with rhMMP7 (7b) and on skin from healthy control
donor after incubation with EGCGþ rhMMP7 (7c). (Ep: epidermis; Der:
dermis). (a) Immunodetection of collagen type VII (anti-collagen type VII,
dilution:1/1,000) on skin from healthy control donor. Bar¼20 mm.
(b) Immunodetection of collagen type VII (dilution 1/1,000) on skin from
healthy control donor after incubation at 371C in a moist chamber with
200 ng of rhMMP7. The immunodetection of collagen type VII is clearly
altered, it appears thin and punctiform. Bar¼ 20mm. (c) Immunodetection of
collagen type VII (dilution 1/1,000) on skin from healthy control donor treated
as follows: rhMMP7 (200 ng) and EGCG 43 ng were co-incubated during
1 hour at 371C in a moist chamber then deposited on to the tissue section
during 48 hours at 371C. Positive structures were comparable to those
observed in panel a. Bar¼ 20 mm.
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subjects that MMP7 ex vivo was able to perform its
proteolytic functions against skin elastic network. After
indirect immunodetection of fibrillin 1 on both human
control skins, a net positivity was observed at the level of
the oxytalan fibers (Cotta-Pereira et al., 1976) in the papillary
dermis, which corresponds also to observations reported by
Sakai et al. (1986). When control skins were incubated with
active MMP7, MMP7 was substantially revealed to have
oxytalan-solubilizing capacity, as demonstrated after indirect
immunodetection of fibrillin 1. In our hands, MMP7 was
shown to hydrolyze ex vivo fibrillin 1, one of the micro-
fibrillar components which belongs to oxytalan fibers and
is associated in the deeper part of the skin with elastic fibers,
but no appreciable elastic-solubilizing capacity was evi-
denced at the level of dermal elastic fibers. This result
concerning elastolytic activity of MMP7 against elastin seems
to contradict the results reported by Filippov et al. (2003) who
conducted in vitro experiments (purified 3H-elastin) with
human macrophage progelatinase B (pro-MMP9), prometal-
loelastase (pro-MMP12), and promatrilysin (pro-MMP7).
Nevertheless, we should be cautious about excluding
elastolytic potentiality from matrilysin on human skin elastic
fibers, the period of incubation being 48 hours only. Longer
period of incubation could be necessary to evidence
hydrolysis of the skin elastin fibers. Furthermore, we
evidenced, when skin sections were overlaid with rhMMP7,
that collagen type VII after indirect immunodetection with
appropriate mAb was clearly broken down. The enzymatic
hydrolysis of these two skin basement membranes-associated
components owing to MMP7 raises the possibility of its
potential major role in blister formation in RDEB of MMP7.
According to our experiment such an ex vivo test provides
more information than in vitro assays using purified substrates
because it closely mimics the in vivo situation where the
investigated metalloproteinase is faced with fibrillin 1,
collagen VII embedded in other matrix macromolecules
which may alter its potential enzymatic activities.
In a previous work conducted in organ culture with the
skin of these same three RDEB patients, we evidenced an
imbalance between collagenase 1 (MMP1) and tissue
inhibitor of metalloproteinase TIMP1 (Bodemer et al.,
2003). In the present work conducted again with organ
culture, we demonstrated that after 3 days of culture the
amounts of MMP7 expressed in culture conditioned media
were increased in affected and unaffected skins of the three
RDEB patients when compared with the two controls donors.
After Western blotting, the molecular weight obtained for
MMP7 is 97 kDa, suggesting that MMP7 is strongly bond to
another component; the component could be a matrix
component, but the exact nature of this component remains
to be investigated. The tissue inhibitor of MMP7 being
TIMP1, and traces of TIMP1 being expressed in affected and
unaffected skins in these RDEB patients (Bodemer et al.,
2003), matrilysin 1 could be active on its substrates
particularly those recovered at the skin basement membrane
that we investigated in this work.
Recently polyphenols from green tea have attracted
attention because of their skin photoprotective effect by
inhibiting UVB-induced expression of matrix degrading MMP
such as MMP2, MMP3, MMP7, and MMP9 in hairless mouse
skin (Katiyar et al., 2001; Vayalil et al., 2004). So we tried to
investigate whether EGCG, which was also demonstrated to
inhibit matrilysin enzymatic activity on synthetic substrate,
kept its enzymatic inhibitory effect on MMP7 in vitro and in
ex vivo experiments. We evidenced after casein zymography
preincubation of rhMMP7 and EGCG before electrophoresis
that the caseinolytic activity of matrilysin was totally
abolished. After electrophoresis of the rhMMP7 alone, the
addition of EGCG in the incubation buffer resulted in a
decrease in the caseinolytic activity of MMP7 proportional to
the amount of EGCG added. These results are in accordance
with those reported by Oneda et al. (2003). We demonstrated
in vitro and ex vivo that EGCG is a good inhibitor of MMP7
and offers a good protection of matrix components suscep-
tible of being degraded by this particular MMP. These ex vivo
studies further emphasized the potential effect of EGCG in
preventing particularly collagen VII, and fibrillin degradation
as occurred in blister formation during EBDR.
It has long been known that polyphenolic compounds
have a high affinity for ECM components rich in PRO such
as collagens and elastin (Tixier et al., 1984). We can thus
speculate on EGCG being linked on the one hand to the
active site of MMP7, and on the other to the matrix
component, this ternary complex being involved in the
abolition of the hydrolysis of the matrix components by
matrilysin 1.
In conclusion, our data provide in vitro and ex vivo
evidences that MMP7 could contribute to the degradation of
ECM components belonging to the dermo-epidermal junction
and thus participate in blister formation observed in patients
suffering from EBDR. Furthermore, we propose that EGCG
could be used beneficially to modulate or control the
epidermal detachment as occurs during pathological states
such as epidermolysis bullosa.
MATERIALS AND METHODS
This study was performed after institutional review board approval of
protocol and informed consent according to the Declaration of
Helsinki Principles. Three RDEB-affected sibling brothers with the
same mutation in COL7A1 and demonstrative intrafamilial pheno-
typic variability were included in this study. The characteristics of
their mutation were described previously (Bruckner-Tuderman et al.,
1989; Bodemer et al., 2003). Two healthy control patients in the
same age group (control 1, aged 20; control 2 aged 24) were also
included in this study.
Skin biopsies
After informed consent was obtained, punch biopsies (punch 4 mm)
were performed under lidocaı¨ne anesthesia. For RDEB patients, two
samples were taken at the same time: one from a new typical
spontaneous blistering and the other from a skin area without any
bullous lesions and scarring feature. For control healthy patients (for
whom only one skin biopsy was taken), the biopsies were performed
at the internal part of the arm. Skin biopsies were divided into two
parts for RDEB patients, one for immunostaining histology and the
second for organ culture and biochemical studies.
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Biochemical studies
The wet weight of skin biopsies was determined, then skin biopsies
were maintained for up to 3 days in DMEM containing: 1.5 mmol.
per liter Ca2þ as recommended previously (Varani, 1998), supple-
mented with 0.2% lactalbumin hydrolysate (Sigma, France), 2 mmol
per liter L-glutamine, 100 U per ml, penicillin, and 100 mg per ml
streptomycin (Boehringer, Manheim, Germany), at 371C in an atmo-
sphere of 95% air, 5%CO2. Cell viability was evaluated by lactate
deshydrogenase determination in conditioned medium.
Western blotting performed on culture conditioned medium
after 3 days of culture
Electrophoresis was carried out using a mini protean II system
(Biorad, Morne La Coquette, France), 10% polyacrylamide gels
(10 cm height, 1.5 mm. thickness) contained buffered solution
consisting of 2.5 ml 1.5 M Tris HCl pH8.8; 100 ml SDS 10%, 4 ml
polyacrylamide, and 3.3 ml of distilled water; stacking gel contained
4% polyacrylamide in 0.5 M Tris HCl pH 6.8. Gels were
polymerized by adding 50 ml of 10% ammonium persulfate and
10 ml of 0.1% TEMED (Biorad, France). Samples were half diluted in
1 M Tris pH6.8 containing 50% glycerol and 0.4% bromophenol
blue (non-reducing conditions) or in 1 M Tris pH 6.8 containing 50%
glycerol, 0.4% bromophenol blue, and 10% b mercaptho-ethanol
(reducing conditions). Samples in reducing conditions were heated
for 1 minute at 1001C. Gels were run under Laemmli conditions
(40 mA, 1 hour).
To show the specificity of the antibody used for the detection of
MMP7 in the conditioned media of RDEB patient, a parallel
electrophoresis of rhMMP7(1 mg) was carried out on a 15%
polyacrylamide gel (10 cm height, 1.5 mm thickness), buffered
solution consisting of 2.5 ml 1.5 M Tris HCl pH 8.8; 100 ml SDS
10%, 4.95 ml polyacrylamide, and 2.4 ml of distilled water; stacking
gel contained 4% polyacrylamide in 0.5 M Tris HCl pH 6.8. Gels
were polymerized by adding 50 ml of 10% ammonium persulfate and
10 ml of 0.1% TEMED (Biorad, France). Samples were half diluted in
1 M Tris pH 6.8 containing 50% glycerol and 0.4% bromophenol
blue (non-reducing conditions) (see Figure 2b).
To assess the molecular weight, a Mr markers, rainbow RPN756
(5ml) (Amersham, Orsay, France) containing myosin (220 kDa,
appears in blue), phosphorylase b (97.3 kDa, brown), bovine serum
albumin (66 kDa, red), ovalbumin (46 kDa, yellow) carbonic
anhydrase (30 kDa, orange), trypsin inhibitor (21.5 kDa, blue), and
lysozyme (14.3 kDa, magenta) in non-reducing conditions were
submitted to a parallel electrophoresis.
Gels were transferred for 75 minutes (75 V) on polyvinylidene
difluoride membrane (Immobilon MILLIPORE, Bedford, MA). Blots
were incubated with anti-MMP7 (clone ID2) (Oncogene, Fontenay s/
Bois, France) mAb diluted 1:500 in phosphate-buffered saline (PBS)
for 1 hour at room temperature. Membranes were washed four times
during 10 minutes with PBS 0.1% Tween 20 (vol/vol) (PBS/ Tween)
and incubated with peroxidase-labeled second antibody diluted
1:1,000 in PBS. They were then washed extensively with PBS/
Tween, treated with Covalight (Ab-Cys, France) for 1 minute and
revealed using KODAK BIOMAX MR film (Sigma, St Louis, MA).
Multiple exposures were examined to ensure that the results
analyzed reflected those produced with linear range of the film.
The quantitative estimation of MMP7 in conditioned media from
skin explants is based on tissue wet weight basis, the tissue being
weighed before incubation. We demonstrated that this quantitative
estimation was strictly correlated with the amount of proteins
contained in the skin explants determined with the Coomassie blue
method of proteins quantification (Mohammedi et al., 1989).
Enzyme assays
Matrilysin (MMP7) was identified by zymography using 0.1%. SDS
(Biorad, France) polyacrylamide gel impregnated with 1 mg per ml
casein (Sigma, Saint Quentin, France) (Fernandez-Resa et al., 1995).
Protein standard underwent a parallel electrophoresis to deter-
mine the molecular weight of lysis bands.
Enzyme assays with EGCG
Active purified matrilysin (MMP7) was purchased from Calbiochem
(France). Casein (1 mg per ml) zymography was used as described
above to demonstrate its enzymatic activity on polyacrylamide gel
after electrophoresis.
Inhibitory effects of EGCG (from Sigma, France) on the matrilysin
casein activity were examined as follows:
1. Buffer (5ml) containing MMP7 (1mg) alone, MMP7 (1 mg) and
30mg/ml EGCG, MMP7 (1 mg) and 60 mg/ml EGCG, were
incubated at 371C in an atmosphere of 95% air, 5% CO2 during
30 minutes before electrophoresis.
2. MMP7 (1mg) alone was electrophoresed and 30 mg/ml EGCG or
60mg/ml EGCG were added to the incubation buffer (Tris-HCl
0.1 M pH 7.4, CaCl2 30 mM, ZnCl2 0.1 mM) during 48 hours at
371C in an atmosphere of 95% air, 5% CO2 before staining of
the electrophoresis gel containing 1 mg/ml of casein for the
visualization of the MMP7 enzymatic activity.
3. EGCG (0mg/ml, 60mg/ml or 120mg/ml) was polymerized in
casein gel (1 mg/ml) then MMP7 (1 mg) alone was electrophor-
esed. Caseinolytic activities were observed after 48 hours at
371C in the incubation buffer.
Quantification of zymogram lysis bands and blots by image
analysis
The average surface (S) of polyacrylamide gel electrophoresis bands
or/and membrane blots was determined semi-automatically by
following its contour with a calibrated electronic slide as described
previously (Beranger et al., 1994).
For zymographic analysis, matrilysin activities were expressed as
gel U¼ pixels (S) gray level/mg wet weight.
Concerning Western blotting analysis, matrilysin 1 was expressed
as dot Q¼ pixels (S) (255gray level) per mg of wet weight (Gogly
et al., 1998).
Histology
Skin biopsies with or without any bullous lesions from the three
RDEB patients were routinely processed for histological investiga-
tions. Serial tissue sections, 6mm thick, prepared with a manual
microtome were stained with hematoxylin eosin to assess tissue
quality (Ganter and Jolles, 1969).
To analyze elastic fibers, the (þ ) catechin fuchsin method was
used (Godeau et al., 1986).
Immunolocalizations of matrilysin (MMP7) (clone ID2) (Onco-
gene) were performed on cryostat tissue sections (8 mm thick) from
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affected and unaffected skins of the three RDEB patients. Cryostat
tissue sections were air dried and fixed with acetone before
immunoperoxidase staining. Appropriated primary antibody and
secondary antibodies were used according to the manufacturer’s
recommendations then tissue sections were counterstained with
hematoxylin for 1 minute before light microscopic observation.
Double-labeled immunostaining
Cryostat tissue section, (8mm) thick, from affected and unaffected
skins of patients were air dried and rinsed in PBS for 10 minutes.
Nonspecific binding was blocked for 30 minutes at 371C with
blocking solution (PBS-Tween 0.05%, 1% BSA, 10% normal horse
serum, 10% normal goat serum) and then incubated overnight at
room temperature with a mixture of primary antibody rabbit anti-
MMP7 (1/25) (Interchim, France) and mouse anti-CD68 (1/25) (clone
PG-M1) (Dako, France) diluted in PBS-Tween (0.05%) bovine serum
albumin (1%) (Sigma, France). Tissue sections were washed in PBS
for 30 minutes and then incubated in the dark with a mixture of
secondary antibody: goat anti-rabbit Hilyte FluorTM 488 conjugated
(1/100) (Euromedex, France) and horse anti-mouse biotinylated
(1/200) (Vector Laboratories, Biovalley, France) diluted in PBS-T
(0.05%) for 2 hours at room temperature. For CD68 immnolocaliza-
tion, after rinsing three times with PBS, slides were incubated with
streptavidin conjugated to fluoroprobes 547 (1/500) (Interchim,
France) 1 hour at room temperature.
Enzyme assays with or without EGCG followed by
immunolocalizations of fibrilllin-1 and collagen VII
Ex vivo MMP7 assay. Experimental procedures were performed on
control healthy human skin cryostat tissue sections (8 mm thick and
four sections per condition).
Active MMP7 (rhMMP7 from Calbiochem, France) at different
quantities, 25, 50, 100, and 200 ng in appropriate buffer (HEPES
10 mM, NaCl 150 mM, CaCl2 5 mM) was laid on four serial tissue
sections, and one tissue section was overlaid with the buffer alone.
The preparations were then incubated in a moist chamber at 371C
for 48 hours; rinsed with the buffer, fixed in absolute ethanol for
1 minute and immunostaining for fibrillin-1 and collagen type VII
was performed following the protocol described above for the
MMP7 immunostaining.
Ex vivo MMP7 inhibition assay
Active MMP7 rhMMP7 from Calbiochem was used at the
concentration of 200 ng in the appropriate buffer.
In a first set of experiments, 200 ng of MMP7 and 43 ng of EGCG
in the appropriate buffer were incubated during 1 hour at 371C, then
laid onto tissue sections (controls with the buffer alone and the buffer
containing EGCG alone), and placed for 48 hours at 371C in a
humidified chamber. The addition of an excess of cold incubation
buffer stopped the reaction then cryostat tissue sections were
processed as described above for the immunodetection of collagen
VII (cloneLH7.2) (Sigma, St Louis, MA) and fibrillin-1 (clone 26)
(Euromedex, France).
In a second set of experiments, cryostat tissue sections were
preincubated with 43 ng of EGCG in the appropriate buffer at 371C
in the moist chamber during 1 hour, then tissue sections were
overlaid with 200 ng of MMP7 for 48 hours at 371C before the
immunodetection of collagen VII and fibrillin-1.
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